Calcium-binding protein 1 (CaBP1), a calmodulin (CaM) homolog, endows certain voltage-gated calcium channels (Ca V s) with unusual properties. CaBP1 inhibits Ca V 1.2 calcium-dependent inactivation (CDI) and introduces calcium-dependent facilitation (CDF). Here, we show that the ability of CaBP1 to inhibit Ca V 1.2 CDI and induce CDF arises from interaction between the CaBP1 N-lobe and interlobe linker residue Glu94. Unlike CaM, where functional EF hands are essential for channel modulation, CDI inhibition does not require functional CaBP1 EF hands. Furthermore, CaBP1-mediated CDF has different molecular requirements than CaM-mediated CDF. Overall, the data show that CaBP1 comprises two structural modules having separate functions: similar to CaM, the CaBP1 C-lobe serves as a high-affinity anchor that binds the Ca V 1.2 IQ domain at a site that overlaps with the Ca 2+ /CaM C-lobe site, whereas the N-lobe/linker module houses the elements required for channel modulation. Discovery of this division provides the framework for understanding how CaBP1 regulates Ca V s.
INTRODUCTION
Voltage-gated calcium channels (Ca V s) serve as a major source of calcium influx in excitable cells (Catterall, 2000) . Because calcium ions are chemical messengers (Clapham, 2007) , influx through Ca V s can directly link membrane potential charges to stimulation of intracellular-signaling cascades (Catterall, 2000) . Although high-voltage activated Ca V s consist of four essential components (Van Petegem and Minor, 2006) , i.e., a Ca V 1 or Ca V 2 pore-forming Ca V a 1 (Catterall, 2000) , a cytoplasmic Ca V b (Dolphin, 2003) , Ca V a 2 d (Davies et al., 2007) , and calmodulin (CaM) (Pitt, 2007) , the composition of these large protein complexes is not monolithic. In some contexts, such as cerebellar and hippocampal neurons (Lee et al., 2002; Zhou et al., 2004) , photoreceptor synapses , and auditory hair cells (Cui et al., 2007; Yang et al., 2006) , members from a family of calcium-binding proteins (CaBPs) homologous to CaM (Haeseleer et al., 2000) can replace CaM. This component exchange has profound effects on how Ca V s respond to calcium entry and results in channels that have strikingly different functional properties than those modulated by CaM (Cui et al., 2007; Few et al., 2005; Lautermilch et al., 2005; Lee et al., 2002; Yang et al., 2006; Zhou et al., 2004 Zhou et al., , 2005 .
When modulated by CaM, many Ca V 1s exhibit a strong calcium-dependent inactivation (CDI) that limits calcium influx during depolarization (Dunlap, 2007) . In contrast, Ca V 1s under the influence of CaBP1, a CaBP abundant in the brain and retina (Haeseleer et al., 2000) , have dramatically altered functional properties. CaBP1 blocks Ca V 1.2 (Zhou et al., 2004 (Zhou et al., , 2005 and Ca V 1.3 (Cui et al., 2007; Yang et al., 2006) CDI and introduces an increase in Ca V 1.2 (Zhou et al., 2004) peak current upon repetitive stimulation, calcium-dependent facilitation (CDF). These effects depend on displacement of CaM from the Ca V a 1 C-terminal IQ domain Zhou et al., 2004) , a channel element that is critical for CaM-mediated CDI (Erickson et al., 2003; Zü hlke et al., 1999) .
As with many calcium-sensor proteins (Burgoyne et al., 2004; Haeseleer et al., 2002; Weiss and Burgoyne, 2002) , both CaBP1 and CaM comprise two lobes that bear a pair of EF-hand calcium-binding motifs (Haeseleer et al., 2000) . Beyond this common architecture, there are a number of differences. CaBP1 is myristoylated at its N terminus, has an N-lobe that is largely insensitive to calcium (K d > 100 mM) (Wingard et al., 2005) , and a longer interlobe linker. Apart from recent NMR structures of individual CaBP1 lobes , little is known about the high-resolution structure of complete CaBPs or the details of how they interact with Ca V s. Thus, it has remained uncertain which CaBP1 features contribute to the stark functional differences that CaBP1 brings to Ca V modulation.
We set out to answer this question with respect to Ca V 1.2 and find that the key element is an interaction between the N-lobe and an interlobe linker residue that is conserved among CaBP family members. We further show that CaBP1 comprises two structural modules having separate functions. The CaBP1 C-lobe shares both structural and functional similarity with the CaM C-lobe and acts as a high-affinity anchor that binds the Ca V 1.2 IQ domain at a site that overlaps with the Ca 2+ /CaM C-lobe binding site. In contrast, the N-lobe/linker module contains the elements required for the unique functional effects CaBP1 has on Ca V 1.2. Delineation of these conserved CaBP structural elements provides the required framework for understanding how this family of calcium-sensor proteins affects Ca V s and other target proteins in a manner distinct from CaM.
RESULTS

CaBP1 N-Lobe and Interlobe Linker Are Crucial for CDI Inhibition
We used two-electrode voltage-clamp recording of Xenopus oocytes to test whether CaBP1 N-terminal myristoylation The N-lobe and C-lobe are shaded green and blue, respectively. CaBP1 N-terminal myristoylation segment and interlobe linker are indicated by the yellow and orange bars, respectively. EF-hand positions are indicated above the sequence according to standard nomenclature (Gifford et al., 2007) . Secondary structure elements are indicated. CaBP1 residues Y56 and E94 are highlighted in red. (B) CaBP1-mediated CDI inhibition is unaffected by myristoylation site mutants. Representative normalized I Ca traces at a test potential of +20 mV for Ca V 1.2 expressed with Ca V b 2a and CaBP1 myristoylation mutants G2A and D2-15 (gray), CaBP1 (orange), or CaM (blue). contributes to CaBP1 modulation of Ca V 1.2 because this lipid anchor is important for CaBP1 modulation of Ca V 2.1 and is an obvious difference from CaM ( Figure 1A ). Examination of calcium currents produced when Ca V 1.2 was co-expressed with a CaBP1 G2A mutant ) that blocks myristoylation (Rocque et al., 1993) demonstrated that CaBP1 G2A could inhibit CDI as effectively as wild-type CaBP1 ( Figures 1B and 1C and Table 1 ). The enzyme that carries out myristoylation is unable to process G2A substrates and is conserved (Rocque et al., 1993) . Nevertheless, to ensure that the N-terminal modification was eliminated, we also examined the consequences of deletion of the entire CaBP1 myristoylation site, CaBP1(D2-15). Similar to CaBP1 G2A, CaBP1(D2-15) fully inhibited CDI (Figures 1B and 1C and  Table 1 ). Thus, N-terminal myristoylation is not required for CaBP1 inhibition of Ca V 1.2 CDI.
Because CaBP1 and CaM (Masino et al., 2000; Tsalkova and Privalov, 1985) lobes fold independently, we designed a set of CaBP1-CaM chimeras based on exchange of three elements (N-lobe, interlobe linker, and C-lobe) and tested their effects on Ca V 1.2 expressed in Xenopus oocytes. We designate the chimeras with three letter names, e.g. MMB, in which the first, second, and third positions denote the N-lobe, interlobe linker, and C-lobe, respectively, and each letter denotes the element origin: ''M'' for CaM, and ''B'' for CaBP1.
All CaM N-lobe chimeras (MMB, MBB, and MBM) lacked the hallmark Ca V 1.2 CDI inhibition caused by CaBP1 and instead supported CDI similar to CaM ( Figures 1D and 1E and Table 1 ). CaM interlobe linker chimeras (MMB, BMB, and BMM) also allowed CDI to proceed. Notably, the chimera having the CaM interlobe linker exchanged into CaBP1, BMB, failed to inhibit CDI. Pull-down assays showed that all chimeras retained ability to interact with the Ca V 1.2 IQ domain (see Figure S1 available online) and eliminate the possibility that the absence of CDI inhibition arose from failure of the chimeras to fold properly and bind the Ca V 1.2 IQ domain. Together, these results suggest that the inability of MMB, MBB, MBM, MMB, BMB, and BMM to inhibit CDI arises from the absence of elements in the CaBP1 N-lobe (MBB, MBM, and MMB) and CaBP1 interlobe linker (MMB, BMB, and BMM). In further support of this, we found that BBM, which has the CaBP1 N-lobe and interlobe linker joined to the CaM C-lobe, blocks Ca V 1.2 CDI, even more potently than CaBP1 ( Figures 1D and 1E ). BBM additionally causes slower Ca V 1.2 activation ( Figure 1D ). Taken together, the results from the chimeras strongly suggest that the key elements underlying the CaBP1 and CaM functional differences with respect to CDI reside in the N-terminal lobe and interlobe linker. Figure 1F ). We tested whether the CaBP1-CaM chimeras retained this property. Chimeras bearing either the CaM N-lobe (MBB, MBM, and MMB) or CaM interlobe linker (MMB, BMB, and BMM) were unable to support Ca V 1.2 CDF. Except for BMB, which introduced a larger progressive loss in current amplitude ( Figures 1F and 1G ), channels expressed with these chimeras were indistinguishable from channels expressed with CaM. In contrast, BBM caused Ca V 1.2 CDF that was $2-fold stronger than that of CaBP1 ( Figures 1F and 1G ). Hence, BBM embodies both main functional properties of CaBP1, the ability to inhibit Ca V 1.2 CDI and the ability to confer CDF. Together, the data indicate that the CaBP1 N-lobe and interlobe linker bear the modulatory elements unique to CaBP1, whereas CaBP1 and CaM C-terminal lobes perform similar functions.
CaBP1 Interlobe Linker Functional Properties
The CaBP1 and CaM interlobe linker lengths differ by four residues ( Figure 1A ), a divergence conserved among CaBPs (Haeseleer et al., 2000) ( Figure S2 ). Given the apparent importance of the interlobe linker, we investigated whether its length, composition, or both were crucial for CaBP1 function. CaBP1 constructs having an interlobe linker composed of the first four (93-96, ''AETA'') or last four interlobe linker residues (97-100, ''DMIG'') failed to inhibit CDI (Figures 2A and 2B) . Replacement of the CaBP1 interlobe linker with a duplication of the CaM interlobe linker (DTDSDTDS), octaalanine (8A), or octa-glycine (8G) also failed to inhibit CDI (Figures 2A and 2B) . Unexpectedly, the protocol used to induce CDF caused Ca V 1.2 to display a strong, calcium-dependent reduction in current amplitude in the presence of all of the CaBP1 interlobe linker mutants ( Figure 2C ). This phenomenon, which we term ''CDI tachyphylaxis,'' is stronger than the small current suppression seen with CaM ( Figure 2D ) and provides evidence that the interlobe linker manipulations did not incapacitate the CaBP1 mutants. This is corroborated by pull-down experiments that show that the individual mutants retain the ability to bind the Ca V 1.2 IQ domain ( Figure S1B ). Further analysis of the DMIG mutant showed that the CDI tachyphylaxis arises from changes in recovery from inactivation ( Figure 2E ). Following a depolarization pulse, Ca V 1.2 coexpressed with CaM shows essentially full recovery after 750 ms. In contrast, $7% of Ca V 1.2 co-expressed with DMIG fail to recover in the same period. Over longer interpulse periods, both CaM and DMIG containing channels recover fully ( Figure 2E ). Taken together, the data from the chimeras and interlobe linker mutants establish that both the length and composition the CaBP1 interlobe linker are crucial for modulation of Ca V 1.2.
Structure
CaBP1 Modulation of Ca V 1.2 N-and C-Lobes Contribute to CaBP1-Ca V 1.2 IQ Domain Affinity We turned to isothermal titration calorimetry (ITC) to investigate how CaBP1 interacts with the Ca V 1.2 IQ domain, the domain that is essential for CaBP1 CDI inhibition (Zhou et al., 2004) . Experiments using individual CaBP1 lobes in the presence of 1 mM calcium, Ca 2+ /N-lobe BP and Ca 2+ /C-lobe BP , revealed that each has a single binding site on the Ca V 1.2 IQ domain (Figures 3A  and 3B and Table 2 ). Ca 2+ /N-lobe BP binding is an endothermic reaction having modest affinity (K d = 1.11 ± 0.08 mM), whereas Ca 2+ /C-lobe BP binds $100-fold stronger via an exothermic reaction that has an affinity (K d = 10.5 ± 1.9 nM) similar to Ca (Kim et al., 2008; .
Unlike the simple, individual lobe-binding isotherms, titration of full-length Ca 2+ /CaBP1 into the Ca V 1.2 IQ domain showed a V-shaped isotherm that could not be attributed to a single binding event ( Figure 3E ). Because Ca 2+ /N-lobe BP and Ca 2+ / C-lobe BP bind to the Ca V 1.2 IQ domain in a competitive manner, we wondered whether the complex isotherm arose from contributions of each lobe. ITC experiments in which equimolar portions of individual Ca 2+ /CaBP1 lobes were titrated into the Ca V 1.2 IQ domain produced a binding isotherm very similar to that of full-length Ca 2+ /CaBP1 ( Figure 3F ). Furthermore, when we used parameters from the single-lobe experiments to simulate the isotherm in which Ca 2+ /N-lobe BP and Ca 2+ /C-lobe BP bind to a single, overlapping IQ domain site, we found excellent correspondence to the measured isotherm ( Figure 3F , red triangles). These results indicate that the ''V''-shaped nature of the isotherm represents a sequence of two events: (1) /N-lobe BP -Ca V 1.2 IQ domain complexes yielded a titration isotherm having a single transition ( Figure 3G ). Analysis using competition ligand binding by displacement (Sigurskjold, 2000) in the context of the thermodynamic cycle in Figure 3H 
Functional EF Hands Not Required for CDI Inhibition
CaBP1 has four EF hands; however, the importance of metal binding to N-lobe EF hands is unclear. EF1 has weak Ca 2+ affinity (Wingard et al., 2005) , and EF2 is nonfunctional due to the lack of a canonical residue at the ''z'' position ( Figure 1A ) (Gifford et al., 2007; Haeseleer et al., 2000) . To test whether CaBP1 inhibition of Ca V 1.2 CDI requires the ability of the CaBP1 EF hands to bind metal ions, we examined the consequences of introduction of a D/A mutation at the ''x'' position of each functional EF hand. This mutation is analogous to those used to dissect CaM EF-hand function (Peterson et al., 1999) and should reduce metal-binding ability substantially. CaBP1 bearing a disrupted EF1 was functionally indistinguishable from wild type (Figures 4A and 4B and Table 1 ). In contrast, EF3, EF4, and EF34 mutations diminished but did not eliminate the ability of CaBP1 to inhibit Ca V 1.2 CDI. Thus, the capacity of CaBP1 C-lobe EF hands to bind metal ions is important but not essential for CDI inhibition. This relative insensitivity to EF-hand disruption stands in contrast to CaM, where functional C-lobe EF hands are required for CDI (Alseikhan et al., 2002; Peterson et al., 1999) . The effects of CaBP1 EF34 are reminiscent of the ability of the CaM EF34 mutant to block CDI (Peterson et al., 1999) and suggest that part of the CaBP1 mechanism may be competition with apoCaM. In contrast to the minor effects on CDI inhibition, the EF3 and EF4 mutants greatly diminished Ca V 1.2 CDF ( Figures 4C  and 4D ) and indicate that CaBP1-mediated CDF requires Ca
2+
binding to the C-lobe.
CaBP1 Crystal Structure
To understand how the CaBP1 N-lobe and interlobe linker contribute to function, we crystallized and determined the structure of the CaBP1 functional core, CaBP1(D2-15). CaBP1 (D2-15) crystallized in the I23 space group and diffracted X-rays to 2.9 Å (Table 3) . Surface-entropy reduction (Derewenda and Vekilov, 2006 ) identified a mutant, CaBP1(D2-15) K130A, that did not alter function (Table 1) , gave crystals having a different space group, P3 1 21 and improved resolution, 2.4 Å , and that enabled solution by MAD (Hendrickson and Ogata, 1997) using selenomethionine-substituted protein. The 2.4 Å structure was used for molecular replacement of the I23 crystal form. Because there were no major differences between the structures, we used chain A from the 2.4 Å structure for analysis. CaBP1 has four EF hands arranged into two lobes. Unexpectedly, a well-ordered interlobe linker (residues 93-100) connects the lobes ( Figure 5A ). N-lobe EF hands, EF1 and EF2, lack ligands; whereas C-lobe EF hands, EF3 and EF4, each contain a calcium ion. The compact structure is different from what has been observed by NMR, which found independent lobes and a disordered interlobe linker . Comparison with crystal structures of compact (Fallon and Quiocho, 2003) and extended (Wilson and Brunger, 2000) Ca 2+ /CaM conformations reveals that the CaBP1 lobe orientation is different from both ( Figure S3A ). Despite the compact conformation, the CaBP1 lobes make few contacts with each other and bury only 270 Å 2 .
Structure
CaBP1 Modulation of Ca V 1.2
The N-lobe is in the calcium-free apo-form. Neither EF1 nor EF2 has electron density indicative of a metal ion, despite crystallization conditions containing millimolar Ca
2+
. The apo-N-lobe shows a number of differences from the Mg 2+ -bound N-lobe NMR structure ) (rmsd Ca = 2.5 Å ). The most notable is in the E1 helix ( Figure 5B ). In the apo-form, E1 extends by an extra turn that -bound structure (Figure 5B ). Additionally, apo-N-lobe EF1 and EF2 are further away from each other and lack the short bhairpin that connects them in the Mg 2+ -bound structure (Figure 5B ). These differences indicate that conformational changes, particularly in EF1, accompany metal binding and are consistent with divalent ion-induced chemical shift changes (Wingard et al., 2005) . Although there are some differences in packing, the N-lobe hydrophobic core is buried in both forms ( Figure S3B ) and does not undergo large changes in exposure seen in the classic apo/Ca 2+ /CaM transition (Gifford et al., 2007; Grabarek, 2006) or in the CaBP1 apo/Ca 2+ /C-lobe transition . The lack of large divalent ion-induced conformational changes agrees with the absence of EF1 D/A functional effects (Figures 4A and 4B) and suggests that N-lobe metal binding is unnecessary for CaBP1-mediated Ca V 1.2 modulation.
The CaBP1 Ca 2+ /C-lobe is similar to the NMR structure (rmsd Ca = 1.3 Å over 60 Ca positions) ( Figure 5C ) and resembles the Ca 2+ /CaM C-lobe ''open'' conformation. The structural similarity is even better when compared to Ca 2+ /CaM crystal structures, regardless of whether the comparison is made with the Ca 2+ /CaM C-lobe alone (Wilson and Brunger, 2000) or bound to a target such as the Ca V 1.2 IQ domain , (RMSD Ca = 1.0 Å over 60 Ca positions for each) (Figure 5D ). This similarity extends to many of the hydrophobic pocket side chains. Consequently, the CaBP1 Ca The most striking aspect of the structure is the well-ordered interlobe linker ( Figures 5A; Figure S3C ), which is clamped to the N-lobe by insertion of Glu94 into a largely hydrophobic N-lobe cleft lined by Tyr56 and Leu91 ( Figure 5E ). This interaction is absent from the NMR structure . Within the N-lobe cleft, the Glu94 side chain is within hydrogen bonding distance of the Met54 backbone carbonyl oxygen. Comparison of non-crystallographically related asymmetric unit monomers reveals that the single helical turn in the C-terminal half of the linker (residues 95-99) forms a hinge point for a 5 rotation between the lobes ( Figure S3D ) and indicates that even in the compact state, there is flexibility between the lobes.
Ca 2+ /C-Lobe BP and Ca 2+ /C-Lobe CaM -IQ Domain Binding Sites Overlap MMB and BBM chimeras having swapped CaBP1 and CaM C-lobes retain the properties of the parent, suggesting that CaBP1 and CaM C-lobes are functionally interchangeable (Figure 1) . This, together with the strong structural similarity between Ca 2+ /C-lobe BP and Ca 2+ /C-lobe CaM bound to the Ca V 1.2 IQ domain ( Figure 5D ) and the prior evidence that CaBP1 acts by competing with CaM for the IQ domain (Zhou et al., 2004) , led us to wonder whether CaBP1 and CaM Ca (Figure 6A ) and supports the idea that the high-affinity Ca V 1.2 IQ domain binding sites for each overlap. To explore this possibility further, we examined the effects of alanine mutations at F1628 and F1631, two residues that serve as anchors for Ca 2+ /C-lobeCaM-CaV 1.2 IQ domain interactions .
ITC experiments with Ca 2+ /C-lobe BP and the F1628A peptide at 15 C, the temperature of our other ITC analyses, gave a small, endothermic signal ( Figure 6B ). Therefore, we evaluated Ca 2+ / C-lobe BP binding to the F1628A peptide at 25 C, where the signal was robust ( Figure 6C ) and compared the results to titration of Ca 2+ /C-lobe BP into the wild-type peptide at the same temperature ( Figure 6D ). The data show that Ca V 1.2 F1628A reduced Ca 2+ /C-lobe BP affinity and binding enthalpy by $48-fold and $4 kcal mol À1 , respectively. The enthalpy reduction magnitude is similar to that caused by F1628A for Ca 2+ / C-lobe CaM and is consistent with a loss of hydrophobic interactions. Measurements with the F1631A peptide ( Figure 6E ) showed an $33-fold and $0.6 kcal mol À1 reduction in affinity and binding enthalpy, respectively. The F1631A change also reduces binding affinity and enthalpy for Ca Figure S5 .
Interlobe Linker Glu94 Is Essential for CDI Inhibition but Not Ca V 1.2 IQ Domain Binding Given that the CaBP1 interlobe linker is well ordered, makes specific interactions with the N-lobe, and is crucial to CDI inhibition, we used an alanine scan to investigate the functional contribution of each residue. Each alanine mutation diminished CDI inhibition ( Figures 7A and 7B) ; however, E94A was the only change that completely eliminated CDI inhibition ( Figures 7A  and 7B ). E94A also caused the appearance of CDI tachyphylaxis ( Figures 7C and 7D ) resulting from changes in recovery from inactivation similar to the DMIG linker mutant ( Figure S4 ). To explore the importance of the Glu94 position further, we tested the effects of E94Q and E94D. E94Q almost completely eliminated CDI inhibition ( Figures 7A and 7B) , whereas E94D allowed partial CDI inhibition. These results indicate that the side chain carboxylate and precise side chain geometry are essential. To probe the N-lobe/Glu94 interaction further, we replaced Tyr56, which contributes many N-lobe pocket/Glu94 contacts, with alanine. This change substantially diminishes CDI inhibition ( Figure 7E and Table 1 ) and further supports the importance of the N-lobe/Glu94 interaction. The paramount functional role for Glu94 agrees well with the structurally defined N-lobe/Glu94 interaction ( Figure 5E ).
Despite the effects that E94A had on function, ITC experiments revealed that the loss of the N-lobe/Glu94 interaction caused by E94A altered DH and DS but spared the affinity for the Ca V 1.2 IQ domain (K d = 0.336 ± 0.097 nM) (Table 2; Figure S5 ). This result prompted us to test whether the ordered nature of the linker was a key element of CaBP1 function. We made a mutant (4G) that maintained the N-lobe/ Glu94 interaction but that converted the C-terminal half of the linker (residues 97-100) to polyglycine. In contrast to the devastating effect of E94A, 4G retained an ability to inhibit CDI that was on par with the single alanine mutants ( Figure 7F ). Thus, although both the Glu94/N-lobe interaction and interlobe linker length (Figure 2 ) are essential for CaBP1 function, the order seen in the C-terminal half of the linker is not.
CaBP1 and CaM-Mediated CDF Are Two Distinct Processes
CaM-mediated Ca V 1.2 CDF requires Ca V b (Findeisen and Minor, 2009; Grueter et al., 2006; Hudmon et al., 2005) and CaMKII (Anderson et al., 1994; Grueter et al., 2006; Hudmon et al., 2005; Yuan and Bers, 1994) . Although CaMKII activation is not necessary for CaBP1-mediated CDF (Zhou et al., 2004) , the extent to which Ca V 1.2 CaM-mediated CDF Zü hlke et al., 1999 Zü hlke et al., , 2000 and CaBP1-mediated CDF (Zhou et al., 2004) (Figures 8A and 8B) . Thus, CaBP1-mediated CDF does not require Ca V b.
Ca V 1.2 CaM-mediated CDF is unmasked by the Ca V 1.2 IQ domain mutation, I1624A Zü hlke et al., 1999 Zü hlke et al., , 2000 (Figures 8A and 8B) . If CaBP1-mediated CDFs were similar to CaM-mediated CDFs, one might expect that I1624A would enhance CaBP1-mediated CDF. Contrary to this expectation, co-expression of Ca V 1.2 I1624A with CaBP1 produces CDF having a magnitude indistinguishable from that seen with CaBP1 and Ca V 1.2 ( Figures 8A and 8B) . Ca V 1.2 IQ domain residues F1618, Y1619, and F1622 are involved in Ca 2+ / CaM N-lobe-IQ domain interactions that play a role in Ca V 1.2 CaM-mediated CDF (Hudmon et al., 2005; Van Petegem et al., 2008) . The triple alanine mutant, F1618A/Y1619A/F1622A (''TripleA''), eliminates CaM-mediated CDF . In contrast, TripleA had no effect on CaBP1-mediated CDF ( Figures 8A and 8B ) or on CaBP1 CDI inhibition ( Figure 8C ). The insensitivity of CaBP1-mediated CDF to manipulations that affect CaM-mediated CDF demonstrates that Ca V 1.2 CaM-mediated CDF and Ca V 1.2 CaBP1-mediated CDF are different and indicates that their underlying molecular mechanisms are different.
DISCUSSION
CaBPs belong to a large calcium-sensor family found throughout the nervous system (Burgoyne et al., 2004; Haeseleer et al., 2002; Weiss and Burgoyne, 2002) and closely resemble CaM Weiss and Burgoyne, 2002) . Accordingly, CaBPs interact with diverse classes of CaM-modulated proteins (Haynes et al., 2006 ): Ca V s (Lee et al., 2002 , Yang et al., 2002 Zhou et al., 2004) , IP3 receptors (Kasri et al., 2004; White et al., 2006; Yang et al., 2002) , TRP channels (Kinoshita-Kawada et al., 2005) , and myosin 1c (Tang et al., 2007) . CaBP-target interactions impart functional changes distinct from those caused by CaM (Kasri et al., 2004; Lee et al., 2002; Yang et al., 2002; Zhou et al., 2004) and may diversify neuronal responses to calcium signals. CaBPs interact with and reshape the functional properties of certain Ca V s (Cui et al., 2007; Haeseleer et al., 2004; Lee et al., 2002; Tippens and Lee, 2007; Yang et al., 2006; Zhou et al., 2004) . Because Ca V s are prominent in cellular calcium-signaling pathways (Clapham, 2007) , CaBP remodeling of the Ca V activity should reach well beyond electrical excitation properties.
CDI is an important type of Ca V feedback modulation that limits cellular calcium entry in response to electrical activity. There are a number of situations in which CDI is overridden (Striessnig, 2007) . One mechanism is CaBP1 substitution for CaM within Ca V multiprotein complexes in retinal and auditory (Cui et al., 2007; Yang et al., 2006) neurons. This component change also happens in the brain (Zhou et al., 2004) , blocks CDI in Ca V 1.2 and Ca V 1.3 (Cui et al., 2007; Yang et al., 2006; Zhou et al., 2004 Zhou et al., , 2005 , and introduces CDF to Ca V 1.2 (Zhou et al., 2004 ). CaBP1 and CaM have two independently folded EF hand-containing lobes separated by Masino et al., 2000; Tsalkova and Privalov, 1985) . This likeness presents the question of which elements endow CaBP1 with the ability to alter Ca V 1.2 behavior differently from CaM. Our chimera-based analysis eliminated a role for CaBP1 N-terminal myristoylation, which is important for Ca V 2.1 modulation , and identified the N-lobe and interlobe linker as the elements that allow CaBP1 to inhibit CDI and enable CDF in Ca V 1.2 (Figure 1 ). The ability of the CaBP1 C-lobe to bind calcium was important but not integral to CDI inhibition. This lack of sensitivity would seem to conflict with the reported calcium dependency of the CaBP1-Ca V 1.2 IQ domain interaction (Zhou et al., 2004) . However, the ability of CaBP1-EF3, EF4, and EF34 mutants to block CDI is reminiscent of the ability of the CaM EF34 mutant to block CDI (Peterson et al., 1999) and suggests that part of the CaBP1 CDI inhibition mechanism could arise from simple competition with apo-CaM binding to Ca V 1.2. Nevertheless, this effect cannot embody the entire mechanism. Our data show that only the BBM chimera but not BMM or MBM chimeras or the E94A mutant block CDI. If competition were the only effect, these mutants would be potent CDI inhibitors. Thus, the data strongly suggest that besides CaM competition, there must be an active role for the CaBP1 N-lobe/Glu94 module in Ca V 1.2 CDI inhibition and this role is the dominant contributor. The CaBP1 crystal structure revealed an unanticipated N-lobe/Glu94 interaction ( Figure 5E ) that is indispensable for CaBP1 CDI inhibition and CaBP1-mediated CDF of Ca V 1.2 (Figure 7) . It is notable that this position is conserved in CaBP2, CaBP4, and CaBP5 ( Figure S2 ), particularly because CaBP4 inhibits Ca V 1.3 CDI (Cui et al., 2007; Yang et al., 2006) . Thus, in addition to serving as part of the CaBP1 module required for Ca V 1.2 CDI inhibition, the N-lobe/Glu94 interaction may have a role in other CaBPs.
The Ca V 1.2 IQ domain is the essential CaM modulation site (Peterson et al., 1999; Pitt et al., 2001 ) and main CaBP1 binding site (Zhou et al., 2004) . Our data uncover a strong structural similarity between the CaM and CaBP1 Ca 2+ /C-lobes ( Figure 5D ). This structural mimicry suggests that both bind the Ca V 1.2 IQ domain in a similar manner. This idea is supported by the interchangeability of CaBP1 and CaM C-lobes with respect to parent molecule Ca V 1.2 modulation (Figures 1D-1G ) and is consistent with the similar functional sensitivity of both proteins to Ca V 1.2 IQ domain mutations (Zhou et al., 2004) . Furthermore, our ITC studies reveal that Ca 2+ /C-lobe BP and Ca 2+ /C-lobe CaM bind with similar affinities to a mutually exclusive Ca V 1.2 IQ domain site ( Figures 6A, 6C , and 6D and Table 2) and that mutations of residues that form anchors for Ca 2+ /C-lobe CaM greatly diminish the ability of Ca 2+ /C-lobe BP to bind (Figures 6C-6F ). Together, these results suggest that CaBP1 and CaM C-terminal lobes have the same main function, formation of high-affinity
Structure
CaBP1 Modulation of Ca V 1.2 attachment to the Ca V 1.2 IQ domain and that this attachment site overlaps. ITC experiments with full-length CaBP1 show that it binds the Ca V 1.2 IQ domain $40-fold stronger than Ca 2+ /C-lobe BP and that the CaBP1 E94A mutation, which eliminates CDI inhibition, has no effect on binding affinity. Superposition of the Ca /C-lobe bind the Ca V 1.2 IQ domain similarly, one candidate CaBP1 N-lobe interaction site would be the Ca V 1.2 IQ domain residues that comprise the CaM Ca 2+ /N-lobe binding site (F1618, Y1619, and F1622) (Fallon et al., 2005; . Nevertheless, functional analysis of the Ca V 1.2 TripleA mutant, which disrupts these anchors and eliminates CaM-mediated CDF , reveals that neither CaBP1-mediated CDF nor CDI inhibition depends on these residues. Therefore, the CaBP1 N-lobe must interact with Ca V 1.2 differently than the Ca 2+ /CaM N-lobe.
Conformational differences between the CaBP1 crystal and solution structures show that CaBP1 can adopt various interlobe conformations. Furthermore, CaBP1 modulation of Ca V 1.2 tolerates substitutions that render the 
CaBP1 Modulation of Ca V 1.2 C-terminal part of the interlobe linker maximally flexible (Figure 7F) . Thus, we propose that CaBP1 binds the Ca V 1.2 IQ domain using a similar C-lobe position to CaM but an alternate N-lobe pose such as an open structure that would maintain the CaBP1 N-lobe/Glu94 interaction but flex in the C-terminal portion of the interlobe linker. This could allow CaBP1 to interact with the Ca V 1.2 cytoplasmic N-terminal domain, a channel element that has the capacity to bind CaBP1 and that is required for CaBP1 modulation of Ca V 1.2 (Zhou et al., 2005) . CaBP1 affects Ca V 1s and Ca V 2s differently. CaBP1 inhibits Ca V 1.2 and Ca V 1.3 CDI (Cui et al., 2007; Yang et al., 2006; Zhou et al., 2004 Zhou et al., , 2005 , whereas it accelerates Ca V 2.1 CDI and changes activation Lee et al., 2002) . Additionally, CaBP1 blocks Ca V 2.1 CDF Lee et al., 2002) . These Ca V 2.1 functional changes require CaBP1 N-terminal myristoylation , a modification that we find irrelevant for CaBP1 modulation of Ca V 1.2. This result is corroborated by the ability of a non-myristoylated CaBP1 splice variant, caldendrin, to block Ca V 1.2 CDI (Tippens and . The mechanistic basis for the difference between Ca V 1.2 and Ca V 2.1 modulation by CaBP1 remains unresolved. CDI and CDF in Ca V 1s and Ca V 2s arise from the actions of different CaM lobes (Dunlap, 2007) Mori et al., 2008) . Similar to Ca 2+ /CaM (Kim et al., 2008; , we find that both CaBP1 lobes can bind the IQ domain. It is tempting to speculate that the differential effects of CaBP1 on Ca V 1 and Ca V 2 CDI and CDF and the differential effects of the CaM lobes with respect to the same processes are related. CaBP1 also binds other CaM-binding channel segments (Dick et al., 2008; Ivanina et al., 2000; Lee et al., 1999) . It is possible that the differential effects also require interactions with these or other channel domains. Delineating how CaBPs act should not only unravel CaBP-specific mechanisms but may help dissect the still imperfectly understood action of CaM with respect to CDI and CDF. Our data provide the framework for investigation of these issues.
We have identified the features that allow CaBP1 to modulate Ca V 1.2 differently from CaM. Our studies reveal an unanticipated essential role for the interlobe linker and show that CaBP1 has two structural modules that encode two separate functions. The CaBP1 C-lobe serves as the IQ domain anchor, whereas the N-lobe/linker module contains the elements required for channel modulation. The elements comprising the N-lobe/ Glu94 interaction are conserved in many CaBPs that interact with diverse targets. Thus, the structural underpinnings outlined here are likely to aid understanding how CaBPs act on a wide range of targets that have dual modulation by CaM and CaBPs.
EXPERIMENTAL PROCEDURES Expression and Purification
Individual human CaBP1-S (AF169148) lobes were expressed as fusion proteins from a pET28 vector denoted ''HMT' in E. coli BL21(DE3)pLysS. CaBP1(D2-15), CaBP1(D2-15) K130A, and selenium methionine-substituted CaBP1(D2-15) K130A were expressed from a pEGST vector in E. coli BL21(DE3)pLysS. Ca V 1.2 IQ domains were made as described previously . Expression and purification details can be found in Supplemental Experimental Procedures.
Crystallization and Refinement
CaBP1(D2-15) was crystallized by hanging drop vapor diffusion at 20 C from equal volumes of protein in buffer A and well solution containing 1.9 M (NH 4 ) 2 SO 4 , 2%-4% 1,2-propanediol, and 0.1 M citrate/sodium citrate (pH 5.5). Native and selenomethionine-substituted CaBP1(D2-15) K130A was crystallized similarly except that 1,2-propanediol was replaced by 5%-7% 1,6-hexanediol. Crystals were flash frozen in well solution plus 20% glycerol. Diffraction data were collected at Beamline 8.3.1 (Advanced Light Source, Lawrence Berkeley National Laboratories) and processed using MOSFLM 7.0.4 (Leslie, 1992) . A three-wavelength MAD experiment was performed on crystals of SeMet-substituted CaBP1(D2-15) K130A. A total of 64 initial selenium positions was located using SHELXD (Uson and Sheldrick, 1999) . After phasing and density modification using DM, the resulting electron density allowed building of an initial model that was improved by iterative cycles of manual building and refinement against native data using Refmac5 (Collaborative Computational Project, 1994) . TLS tensors were used throughout refinement. Tight NCS restraints were employed initially and relaxed in later refinement cycles. Each final model consists of six CaBP1 monomers.
ITC
Titrations were performed at 15 C or 25 C using a VP-ITC Microcalorimeter (MicroCal). Samples were dialyzed overnight at 4 C (Slide-A-Lyzer, 3.5 kDa C), protein concentrations were determined by absorbance at 280 nm . All samples were degassed for 5 0 prior to loading into the VP-ITC. Ca V 1.2 IQ domain peptide at concentrations of 5.5 or 7.5 mM were titrated with 75 mM CaBP1 constructs using a schedule of one 4 ml titrant injection followed by 29 injections of 10 ml. For competition experiments, 7.5 mM Ca V 1.2 IQ domain peptide was preincubated with 50 mM of Ca 2+ /N-lobe BP and titrated with a solution of 75 mM of CaBP1. To correct the baseline, either heat of dilution from titrations of injectant into buffer was subtracted ( Figures 3A and  3D ), or the final titration points were used to estimate the baseline ( Figures 3B and 3F-3H (Sigurskjold, 2000) that takes into account that both ligands are added simultaneously. Thus, the stoichiometric concentration of B in the calorimeter cell, Equation (26) (NP 446303) in pGEMHE, and Ca V a 2 d-1 (NM_00182276) in pcDNA3.1 were co-expressed with either Homo sapiens CaM (NM_006888) or the short isoform of human CaBP1-S (AF169148) in pGEMHE for Xenopus oocyte two-electrode voltage-clamp experiments. Point mutations were introduced using QuikChange (Stratagene). For chimera construction, CaM and CaBP1 were divided into three elements: N-lobe (CaM 1-78 and CaBP1 1-92), linker (CaM 79-82 and CaBP1 93-100 for CaBP1), and C-lobe (CaM 83-149 and CaBP1 101-167). All chimeras having the CaBP1 N-lobe include the N-terminal myristoylation domain. Inter-element junctions were framed by introduction of EcoRV sites generated using QuikChange. Elements were excised using EcoRV and either HindIII or XhoI present in the parent vector and combined to produce the chimeras. Following chimera generation, junction sites were returned to the native sequence using QuikChange. After overnight linearization (XhoI for pcDNA3.1 and NheI for pGEMHE), capped mRNAs were synthesized (T7 mMessenger kit; Ambion) according to the manufacturer's protocols. RNA concentrations were determined by A 260nm . A total of 50 nl of Ca V a 1 , Ca V b, Ca V a 2 d-1, and CaBP1 or CaM mRNA at a molar ratio of 1:1:1:20 was injected into defolliculated stage VI Xenopus oocytes using Nanoject II injector (Drummond Scientific). Oocytes were kept at 18 C Structure CaBP1 Modulation of Ca V 1.2 in ND96 medium containing penicillin and streptomycin. Two-electrode voltage-clamp experiments were performed 2-4 days postinjection using a GeneClamp 500B (Axon Instruments) amplifier controlled by a 1200 MHz processor computer (Celeron, Gateway) running CLAMPEX 8.2.0.244, and digitized at 1kHz with a Digidata 1332A (Axon Instruments). Immediately prior to recording, oocytes were injected with 47 nl of 100 mM BAPTA to minimize Ca
2+
-activated Cl À current. Recording solutions contained either 40 mM Ba (OH) 2 or 40 mM Ca(NO 3 ) 2 , 50 mM NaOH, 1 mM KOH, and 10 mM HEPES, adjusted to pH 7.4 using HNO 3 . Electrodes were filled with 3 M KCl and had 0.3-2.0 MU resistances. Leak currents were subtracted using a P/4 protocol. Currents were analyzed with Clampfit 8.2 (Axon Instruments). Oocytes were superfused during recording using a Valvelink 16 controller (Automate Scientific). Holding potential for all experiments was À90 mV. Results are from at least two independent oocyte batches. t i300 values were calculated from normalized currents at +20 mV and represent the percent inactivation after 300 ms. Inactivation t values were calculated at a test potential of +20 mV as described (Findeisen and Minor, 2009 ). CDF was elicited by a train of 40, 50 ms pulses to +20 mV at 3 Hz and calculated as the ratio of the peak current from the last pulse divided by the first. Recovery from inactivation was measured by a protocol with two 450 ms pulses to +20 mV separated by variable time intervals. Consecutive sweeps were separated by 30 s.
Pull-Down Experiments
Bacterial pellets from a 50 ml culture of CaBP1, CaBP1 mutants, CaM, or CaBP1/CaM chimeras co-expressed with HMT-tagged Ca V 1.2 IQ domain were resuspended in 1.6 ml lysis buffer (10% sucrose, 150 mM KCl, 5 mM MgCl 2 , 1 mM CaCl 2 , 25 mg/ml DNAaseI, 1 mM PMSF, and 100 mM Tris [pH 8.8]) and lysed by sonication. A total of 100 ml amylose resin in buffer AmyA (250 mM KCl, 1 mM CaCl 2 , and 10 mM HEPES/KOH [pH 7.4]) was incubated with the bacterial lysate for 30 min at 4 C with gentle agitation. After four washes with 500 ml AmyA, bound material was eluted in 500 ml AmyA containing 10 mM maltose. Input and eluate fractions were analyzed by SDS-PAGE.
ACCESSION NUMBERS
CaBP1 and CaBP1 K130A coordinates and structure factors are deposited with the RCSB under codes 3OX5 and 3OX6, respectively. Comparison of the core domain sequences of CaBP1, CaBP2 (NM_016366.2), CaBP4 (NP_660201), and CaBP5 (AAF25798). Secondary structure elements, EF hand positions, N-lobe, and C-lobe domains from the CaBP1 crystal structure are indicated. Y56 and E94, which form the CaBP1 E94/Nlobe interaction, are highlighted in red. -bound (grey) (2K7B) states. N-lobe hydrophobic core are represented as stick models and labeled. C, Main chain B-factor plot for CaBP1. Red bar indicates the linker positions. D, Superposition of the N-terminal lobe of two non-crystallographically related monomers from the P3 1 21 crystal form shows the 5° displacement of C-lobe.
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